Genomic Analysis and Resistance Mechanisms in Shigella flexneri 2a Strain 301

Zhen Zhu1, Xuzheng Zhou1, Bing Li1

  • 1Key Laboratory of New Animal Drug Project of Gansu Province, Key Laboratory of Veterinary Pharmaceutical Development of Ministry of Agriculture, Lanzhou Institute of Husbandry and Pharmaceutical Sciences , CAAS, Lanzhou, People's Republic of China .

Microbial Drug Resistance (Larchmont, N.Y.)
|August 31, 2017
PubMed

Insights

Multidrug resistance (MDR) in Shigella flexneri is a growing threat. Genomic analysis revealed specific mutations in genes like metG, gyrB, and rob contributing to antibiotic resistance, highlighting the need for careful antimicrobial drug selection.

Area of Science:

  • Microbiology and Genetics
  • Genomics and Bioinformatics
  • Infectious Diseases

Background:

  • Shigella flexneri causes shigellosis, a significant disease in developing nations.
  • Antibiotic resistance, particularly multidrug resistance (MDR), poses a major global health challenge.
  • Molecular mechanisms underlying bacterial MDR remain incompletely understood.

Purpose of the Study:

  • To investigate the genomic basis and evolution of antibiotic resistance in Shigella flexneri.
  • To identify specific genetic mutations conferring resistance to ciprofloxacin (CIP), ceftriaxone (CRO), and tetracycline.
  • To understand the molecular mechanisms driving MDR in this pathogen.

Main Methods:

  • Whole-genome sequencing of Shigella flexneri populations under sequential antibiotic selection.
  • Identification and analysis of chromosomal antibiotic resistance genes.
  • Detection of single nucleotide polymorphisms (SNPs) associated with MDR and single-drug resistance.

Main Results:

  • 82 chromosomal antibiotic resistance genes were identified.
  • 40 SNPs in 8 genes and 3 intergenic regions, including mutations in metG, were consistently found under all three antibiotic pressures.
  • Nonsynonymous mutations in gyrB, ydgA, rob, and narX were observed under CIP or CRO selection.

Conclusions:

  • Genomic analysis successfully identified key mutations contributing to antibiotic resistance in Shigella flexneri.
  • Specific SNPs in genes like metG, gyrB, and rob are crucial for developing MDR.
  • Judicious selection and use of antimicrobial agents are essential for effective shigellosis treatment and combating resistance.